Searching over 5,500,000 cases.


searching
Buy This Entire Record For $7.95

Download the entire decision to receive the complete text, official citation,
docket number, dissents and concurrences, and footnotes for this case.

Learn more about what you receive with purchase of this case.

In re Avandia Marketing, Sales Practices and Product Liability Litigation

United States District Court, E.D. Pennsylvania

February 28, 2017

IN RE AVANDIA MARKETING, SALES PRACTICES AND PRODUCT LIABILITY LITIGATION THIS DOCUMENT APPLIES TO County of Santa Clara
v.
GSK 10-CV-1637 No. 07-MD-01871

          MEMORANDUM OPINION

          RUFE, J.

         I. Introduction

         Plaintiff has filed a Motion Appealing the Twenty-Fourth Report and Recommendation of the Special Master (“R&R 24”). R&R 24 addressed an unusual situation: five years into this litigation, in a case that was filed in-rather than removed to-federal court, Plaintiff filed a Motion to Dismiss the case for lack of subject matter jurisdiction, claiming that the parties were not completely diverse at the outset of the case, and therefore this Court lacks subject matter jurisdiction over the case.[1] R&R 24 concluded that jurisdiction was and is proper in this case.

         Upon consideration of Plaintiff's Motion appealing the R&R, Defendant's Response, and Plaintiff's Reply, and pursuant to this Court's power to conduct a de novo review of proposed recommendations to which objections are made, [2] the Court will approve and adopt R&R 24 for the reasons set forth below.

         II. Background

         The Avandia Multidistrict Litigation (“MDL 1871”) was created by the United States Judicial Panel on Multidistrict Litigation, pursuant to 28 U.S.C. § 1407, to consolidate cases in federal court that “arise from allegations that certain diabetes drugs manufactured by [Defendant GlaxoSmithKline]-Avandia and/or two sister drugs containing Avandia (Avandamet and Avandaryl)-cause an increased risk of heart attack and other physical injury, and that GSK failed to provide adequate warnings concerning that risk.”[3] Both personal injury claims and sales and marketing claims were consolidated in MDL 1871. The stated goal of the panel in creating the MDL was to eliminate duplicative discovery, avoid inconsistent pretrial rulings, and conserve the resources of the parties.[4] In its role as the MDL Court, this Court has, with the assistance of court-appointed Special Discovery Masters and Settlement Masters, directed discovery efforts, resolved common questions of law, decided Daubert motions, and overseen the settlement of tens of thousands of individual cases.

         In 2010, the County of Santa Clara (“the County”), individually and on behalf of the People of the State of California (“the People”), filed this sales and marketing suit against Defendant GlaxoSmithKline (“GSK”), alleging violations of California's False Advertising Law (“FAL”) in the marketing of Avandia. Plaintiff opted to file the suit in federal court, asserting that the federal courts had diversity jurisdiction over the controversy, as Plaintiff and Defendant were citizens of different states. Plaintiff originally filed suit in the United States District Court for the Northern District of California, and the Judicial Panel on Multidistrict Litigation subsequently transferred the case to MDL 1871 by a Conditional Transfer Order dated March 11, 2010. There were no objections to the transfer. Before an answer was filed, Plaintiff filed a first amended complaint on June 10, 2010. The amended complaint, like the original complaint, alleged one count: “Violations of the California Business and Professions Code Section 17500, et seq., by Plaintiff County of Santa Clara, individually, and on behalf of the People of the State of California as against all Defendants.”[5]

         Defendant filed a motion to dismiss the amended complaint, seeking dismissal of claims raised by the County on its own behalf, arguing that the County lacked standing under the FAL, and further arguing that the County had failed to state a claim on behalf of the People. The Court found that the County did not have standing to sue on its own behalf, but that it had adequately pled its claims on behalf of the People.[6]

         After the Court ruled on the motion to dismiss, GSK filed an answer and the parties began discovery efforts. In November 2012, while discovery was ongoing, the Attorney General of California, as counsel for the People of the State of California, entered into a stipulated Final Judgment with GSK in California state court, settling claims similar to those brought by the County in federal court. GSK agreed to curtail or modify certain marketing activities, and to pay the State of California approximately $7.3 million. The Final Judgment released GSK from similar claims under the FAL, but excluded claims brought by the Santa Clara County Counsel's office for violations of the FAL to which residents of Santa Clara County were exposed. The exception to the release “applies to and in favor of only persons or entities resident in the County.”[7] Because the Final Judgment limited the scope of Plaintiff's claims, the Court granted Plaintiff leave to file a Second Amended Complaint (“SAC”). The SAC was filed on February 26, 2013 and named as Plaintiffs “County of Santa Clara and the People of the State of California.”[8] GSK filed an answer, and the parties continued discovery efforts.

         Shortly thereafter, on May 10, 2013, GSK filed a motion for partial summary judgment, which sought to limit the scope of the County's claims. First, the motion asked the Court to interpret the release exclusion provision in the Final Judgment as limiting recovery not just to Santa Clara residents exposed to allegedly misleading Avandia marketing, but to those Santa Clara residents who could establish that that exposure occurred within the County limits. The Court denied this request, as it was not supported by the language of the Final Judgment. GSK also asked the Court to make certain rulings regarding the calculation of restitution, should liability be established. The Court dismissed this issue without prejudice as premature.

         As fact and expert discovery continued to proceed, on December 22, 2014, GSK filed another motion for partial summary judgment, seeking dismissal of the County's claim for restitution under the FAL. On February 10, 2015, before the issue was fully briefed, Plaintiff filed the instant Motion to Dismiss for Lack of Jurisdiction.[9] Although Plaintiff had opted to file suit in federal court in 2010, then asserting that the federal court had diversity jurisdiction over the case, and no party had suggested that the Court lacked jurisdiction during the subsequent five years of litigation, Plaintiff now sought dismissal of the action so that it could be refiled in state court.

         The Motion to Dismiss for Lack of Jurisdiction was referred to the Special Master for an R&R. The Special Master reviewed the relevant case law, analyzed the facts of the case, and concluded that this Court had diversity jurisdiction under the initial complaint, as the County had asserted therein. Specifically, the Special Master concluded that the County, and not the People, was the real party in interest to this suit, and as the County is a citizen of California, and GSK is not, the parties were diverse. Plaintiff filed objections to the R&R. The matter was fully briefed and the Court held oral argument on the issue.

         III. Plaintiff's Objections to R&R 24

         Plaintiff objects to the R&R on several grounds. Plaintiff maintains that diversity jurisdiction has never existed in this case, because the People, that is, the State of California, is the only possible plaintiff in this case. Additionally, Plaintiff disagrees with the R&R's interpretation of Ninth Circuit cases, arguing that the case law supports a finding that there is no diversity of citizenship in this case. Plaintiff contends that California courts routinely refuse to exercise diversity jurisdiction in FAL cases brought by prosecutors on behalf of the People, and this Court should follow their lead.[10] Plaintiff also argues that R&R 24 “betrays a fundamental misunderstanding” of an earlier ruling by the Court in this case. Defendant agrees with the findings of the Special Master, asserting that the County is the real party in interest in this case because it is the County that stands to benefit.

         IV. Discussion

         A. The County Is the Real Party in Interest

         Federal district courts have original jurisdiction of civil actions “between . . . citizens of different States” where the amount in controversy exceeds $75, 000.[11] It is well settled that diversity jurisdiction is based on the citizenship of the parties to a case, and that a state is not a citizen for diversity purposes.[12] A county is considered a citizen for diversity purposes.[13] To determine whether diversity of citizenship exists, a court must “look behind the pleadings” and inquire into the real party in interest because “in cases involving a State or state official, . . . a State's presence as a party will destroy complete diversity.”[14] “The defense of lack of subject matter jurisdiction cannot be waived, and the court is under a continuing duty to dismiss an action whenever it appears that the court lacks jurisdiction.”[15] Diversity jurisdiction depends on the status of the parties as they existed at the time the complaint was filed.[16] Thus, the Court must look to the original complaint in determining the existence of diversity of citizenship.

         Plaintiff contends that the R&R misapplied a 2011 Ninth Circuit case upon which it relied, as well as a subsequent Ninth Circuit case, and that the cases instead support a finding that there is no diversity of citizenship in this case. The Court disagrees.

         In Department of Fair Employment & Housing v. Lucent Technologies, Inc., the Ninth Circuit established a new standard for determining the real party in interest, holding that the determination should be made based on the record of the case as a whole, and that “general governmental interest[s] will not satisfy the real party to the controversy requirement.”[17] The court considered whether diversity jurisdiction was proper in an action filed by the California Department of Fair Employment and Housing (“DFEH”) in state court on behalf of an aggrieved employee, and subsequently removed to federal court by the defendant-employer.[18] The Ninth Circuit held that the real party in interest for diversity purposes was not the State of California (acting through the DFEH), but rather the individual on whose behalf the DFEH had brought suit.[19] Quoting a seminal Supreme Court case, the Lucent court held that a state's general interest in the welfare of its people will not make the state the real party in interest unless “the relief sought is that which inures to it alone.”[20]

         The court in Lucent examined whether the state had a “substantial state interest” distinct from the relief sought on behalf of the aggrieved individual.[21] The court focused on the broad equitable relief sought, noting that it did not constitute a substantial state interest because it “could be obtained by the individual aggrieved, ” even though such relief would affect employees of the company at work locations throughout California.[22] The court found that since the interests of the DFEH were merely “tangential to the alleged relief sought” for the individual, the true party in interest was the individual on whose behalf the DFEH had sued.[23]

         Applying the standard it announced in Lucent, the Ninth Circuit came to the opposite conclusion in Nevada v. Bank of America Corp., in which the Attorney General of Nevada sued Bank of America under a state deceptive trade practices law in state court for allegedly misleading customers about mortgage and foreclosure procedures.[24] The Ninth Circuit distinguished the facts in Nevada from those in Lucent and found that the State of Nevada was the real party in interest.[25] The court noted that “the Nevada Attorney General sued to protect the hundreds of thousands of homeowners in the state allegedly deceived by Bank of America, as well as those affected by the impact of Bank of America's alleged frauds on Nevada's economy.”[26] The court underscored that foreclosures “work a widespread and devastating injury” affecting not just defrauded borrowers, but also the economy of the state as a whole.[27] In holding that the state of Nevada was the real party in interest, the Ninth Circuit focused on the relief sought and noted that the state stood to benefit from enforcement of a consent judgment, civil penalties under the statute, injunctive relief, and recoupment of costs of investigations into Bank of America's practices.[28]

         The Court agrees with the R&R that Lucent supports a finding that the real party in interest is the County, and Nevada does not alter that conclusion. Instead, Nevada reinforces Lucent's holding that a court must examine “the essential nature and effect of the proceeding as it appears from the entire record” to determine the real party in interest.[29] Here, as discussed below, the record establishes that the real party in interest is the County.

         In addition to arguing that Lucent and Nevada compel the conclusion that the State is the real party in interest in this case, Plaintiff cites several district court decisions in support of the contention that California courts “have uniformly rejected diversity jurisdiction” where public prosecutors bring cases on behalf of the People under the FAL or similar statutes.[30] None of these cases presents a set of facts substantially similar to those presented here, and none shares the procedural posture of this case. Additionally, four of the cases cited by Plaintiff pre-date Lucent, and therefore do not apply the governing standard discussed above.[31] Of the cases that came after Lucent, some inexplicably do not mention Lucent.[32]

         Additionally, the cases cited by Plaintiff were all decided in the context of a motion for remand.[33] The rulings in favor of remand in these cases are often based on the principle that “a court must construe the removal statute strictly and reject jurisdiction if there is any doubt regarding whether removal was proper.”[34] The removal statute is not a concern in cases where the plaintiff originally brought suit in federal court by invoking diversity jurisdiction, [35] as the County here did.

         The record in this case supports the conclusion that the County is the real party in interest, and has been since the case was filed. The original complaint stated, in relevant part:

In short, GSK bilked purchasers, including California diabetics, their insurers, public healthcare providers, public entities, and government payors, including Plaintiff County of Santa Clara, out of hundreds of millions of dollars by making false representations that Avandia was better at lowering blood sugar and could decrease diabetics' cardiovascular risks. Plaintiff County of Santa Clara alone paid approximately $2 million for Avandia between May 1999 and July 2009 . . .[36]

         In addition to restitution and civil penalties, the County sought treble damages, prejudgment interest, fees and costs, and any other relief ...


Buy This Entire Record For $7.95

Download the entire decision to receive the complete text, official citation,
docket number, dissents and concurrences, and footnotes for this case.

Learn more about what you receive with purchase of this case.